Originally published September 19, 2007 at 12:00 AM | Page modified September 19, 2007 at 1:59 PM
Gates Foundation adds to TB fight
The threat of tuberculosis seemed distant in America until an Atlanta attorney flew off for an international honeymoon last spring. The case of Andrew...
Seattle Times science reporter
Information
King County TB report: www.metrokc.gov/health/news/07081701.htm
The threat of tuberculosis seemed distant in America until an Atlanta attorney flew off for an international honeymoon last spring.
The case of Andrew Speaker, who was infected with a drug-resistant strain, showed how ill-prepared the world is to deal with the contagious lung disease, a top official from the Bill & Melinda Gates Foundation said Tuesday, announcing the Seattle philanthropy's biggest package of grants ever to fight tuberculosis.
The $280 million commitment brings the foundation's total spending on TB research to $740 million.
"The goal is to translate promising scientific leads into tools that can save millions of lives," said Dr. Tachi Yamada, president of the foundation's Global Health Program.
Tuberculosis kills nearly 2 million people a year, mostly in poor nations. About a third of the world's population is infected with the bacteria that cause the disease. Immigration and travel are contributing to a resurgence in places where TB was largely wiped out decades ago.
King County reported 145 new cases in 2006, 16 percent more than the previous year.
The new money will build on previous Gates grants to accelerate development of tuberculosis vaccines and improve techniques for diagnosing the disease, Yamada said.
The foundation is also making its first foray into research on new tuberculosis drugs, with the hope of replacing a cumbersome regimen that now takes six months or more to cure an infection.
"I think most people would argue the intervention that is most likely, and most likely to have the biggest impact, would be a new drug," said David Sherman, a molecular geneticist at Seattle Biomedical Research Institute (SBRI).
A consortium led by Sherman was awarded $7.5 million to develop methods to quickly screen possible drug candidates and identify the bacterium's vulnerabilities.
"I have a lot of optimism," he said.
Most tools to fight TB haven't improved significantly in decades, especially in the developing world, Yamada pointed out. The disease is still diagnosed by examining sputum samples under a microscope — an approach that misses about half of infections. It takes 45 days to culture bacteria to confirm a positive test.
"Many people with tuberculosis are never diagnosed and do not receive treatment in a timely manner," said Dr. Giorgio Roscigno, CEO of the Geneva-based Foundation for Innovative New Diagnostics, which will receive $62 million over five years.
The group's goal is to develop an accurate TB test that gives results in two hours or less.
The disease spreads through the air, so untreated patients can infect others with every cough. Those who do get treatment must take several pills a day for six to nine months.
Many people don't complete the entire course of medication, contributing to the emergence of drug-resistant bugs. Speaker's case was so persistent it required surgery to cut away infected lung tissue.
TB treatments haven't kept pace with new technology because "quite frankly, for the last 50 years, no one has really tried," said Dr. Peter Small, of the Gates Foundation's tuberculosis program.
Historically, drug companies have been reluctant to invest in TB and other diseases of the developing world that offer little prospect of profit. The bug itself also is very tough to work with, Sherman said.
"It takes weeks to get a culture on a plate," he said. "It's the only one of the major pathogens where all you have to do is breathe to get it."
At SBRI, researchers work in a special lab and wear full protective garb, including a respirator, when they handle the bacteria.
Yamada, the former chief of research for European pharmaceutical giant GlaxoSmithKline, said drug companies have stepped up their TB research in recent years.
Companies also will be eager to develop and market any new drugs that come out of the Gates-funded projects, predicted Yamada, who was named an honorary knight Tuesday by Queen Elizabeth II in recognition of his work with GlaxoSmithKline.
The biggest chunk of new funding, $200 million, will go to the Aeras Global TB Vaccine Foundation to pay for early clinical trials on six vaccine candidates.
"We expect one or two of these candidates may make it all the way," said Dr. Jerald Sadoff, the organization's president and CEO. If so, a vaccine could be approved as early as 2015.
Research on new treatments, including Sherman's project, will get a total of $18 million.
Sandi Doughton: 206-464-2491 or sdoughton@seattletimes.com
Copyright © 2007 The Seattle Times Company
Property taxes: Appeals shoot up in King, Snohomish Counties
Hard times for tourist towns means good deals for travelers
Landmark Smith Tower mostly vacant
Tukwila residents rally against light-rail noise
Seattle safety project: A snake shelter on Beacon Hill

2009 fireworks time lapse
With strict parking rules enforced at this year's July 4th celebration on Wallingford Ave North, less cars and more spectators filled the streets.
Entertainment | Top Video | World | Offbeat Video | Sci-Tech
shopping

events for Sunday, Jul. 5th
- Blackbird Spring Half-Yearly Sale
- REI Summer Sale and Clearance
- Pink Ginger First Anniversary Sale
- Evo Independence Sale
editors' picks
- Contemporary furniture
- Electronics, where to buy
- Stationery, pens & postcards
- Wedding gowns & partywear
- Plasma and LCD beware; OLED screens ready to go mainstream
- Former NFL MVP McNair killed
- Russell Branyan, Mariners fight off the Red Sox
- Palin takes to Web for hints of political future
- Fourth of July festivals and fireworks in Seattle, the suburbs and beyond
- The Blotter | Man pistol-whipped after argument at nightclub
- Desert-lobster dispute turns pair into sagebrush heroes
- Close-up | Prison guards intercept carrier pigeon with a cellphone
- Landmark Smith Tower mostly vacant
- Woman accuses Sounders FC player Nate Jaqua of sexual assault, seeks more than $10 million
- Palin resigning as Alaska governor
764 - Seattle Mariners at Boston Red Sox: 07/04 game thread
244 - Reports: NKorean missile arrives at launch site
100 - Former NFL MVP McNair killed
78 - Hatred for the NBA runs deep, but don't take it out on the players
77 - Palin links resignation to 'higher calling' and blasts media in Facebook posting
59 - Mariners score unlikely win over Red Sox in battle of bullpens
58 - Tukwila residents rally against light-rail noise
47 - Man pistol-whipped after argument at nightclub
43 - Property taxes: Appeals shoot up is King, Snohomish Counties
35
- Plasma and LCD beware; OLED screens ready to go mainstream
- Merchant Marine veterans fight for recognition
- Property taxes: Appeals shoot up in King, Snohomish Counties
- Close-up | Prison guards intercept carrier pigeon with a cellphone
- Pre-grill drill: marinate steaks
- Lake Washington's sockeye run may hit a record low
- Amtrak cleared for 2nd daily train to Vancouver, B.C.
- Concert Review | Green Day blasts off 4th weekend with KeyArena show
- Hard times for tourist towns means good deals for travelers
- Yakima teacher reprimanded for sending 5-year-old student home with bag of feces in backpack



